Lamkanfi Mohamed, Kanneganti Thirumala-Devi, Van Damme Petra, Vanden Berghe Tom, Vanoverberghe Isabel, Vandekerckhove Joël, Vandenabeele Peter, Gevaert Kris, Núñez Gabriel
Department of Pathology and Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.
Mol Cell Proteomics. 2008 Dec;7(12):2350-63. doi: 10.1074/mcp.M800132-MCP200. Epub 2008 Jul 30.
The aspartate-specific cysteine protease caspase-1 is activated by the inflammasomes and is responsible for the proteolytic maturation of the cytokines IL-1 beta and IL-18 during infection and inflammation. To discover new caspase-1 substrates, we made use of a proteome-wide gel-free differential peptide sorting methodology that allows unambiguous localization of the processing site in addition to identification of the substrate. Of the 1022 proteins that were identified, 20 were found to be specifically cleaved after Asp in the setup incubated with recombinant caspase-1. Interestingly, caspase-7 emerged as one of the identified caspase-1 substrates. Moreover half of the other identified cleavage events occurred at sites closely resembling the consensus caspase-7 recognition sequence DEVD, suggesting caspase-1-mediated activation of endogenous caspase-7 in this setup. Consistently recombinant caspase-1 cleaved caspase-7 at the canonical activation sites Asp(23) and Asp(198), and recombinant caspase-7 processed a subset of the identified substrates. In vivo, caspase-7 activation was observed in conditions known to induce activation of caspase-1, including Salmonella infection and microbial stimuli combined with ATP. Interestingly Salmonella- and lipopolysaccharide + ATP-induced activation of caspase-7 was abolished in macrophages deficient in caspase-1, the pattern recognition receptors Ipaf and Cryopyrin, and the inflammasome adaptor ASC, demonstrating an upstream role for the caspase-1 inflammasomes in caspase-7 activation in vivo. In contrast, caspase-1 and the inflammasomes were not required for caspase-3 activation. In conclusion, we identified 20 new substrates activated downstream of caspase-1 and validated caspase-1-mediated caspase-7 activation in vitro and in knock-out macrophages. These results demonstrate for the first time the existence of a nucleotide binding and oligomerization domain-like receptor/caspase-1/caspase-7 cascade and the existence of distinct activation mechanisms for caspase-3 and -7 in response to microbial stimuli and bacterial infection.
天冬氨酸特异性半胱氨酸蛋白酶caspase-1由炎性小体激活,在感染和炎症过程中负责细胞因子IL-1β和IL-18的蛋白水解成熟。为了发现新的caspase-1底物,我们利用了一种全蛋白质组无凝胶差异肽分选方法,该方法除了能鉴定底物外,还能明确加工位点的定位。在鉴定出的1022种蛋白质中,有20种在与重组caspase-1孵育的实验装置中被发现是在天冬氨酸之后被特异性切割的。有趣的是,caspase-7是鉴定出的caspase-1底物之一。此外,其他鉴定出的切割事件中有一半发生在与caspase-7共有识别序列DEVD非常相似的位点,这表明在该实验装置中caspase-1介导了内源性caspase-7的激活。一致地,重组caspase-1在典型激活位点天冬氨酸(23)和天冬氨酸(198)处切割caspase-7,并且重组caspase-7加工了一部分鉴定出的底物。在体内,在已知能诱导caspase-1激活的条件下观察到了caspase-7的激活,包括沙门氏菌感染以及微生物刺激与ATP联合作用。有趣的是,在缺乏caspase-1、模式识别受体Ipaf和Cryopyrin以及炎性小体接头ASC的巨噬细胞中,沙门氏菌和脂多糖+ATP诱导的caspase-7激活被消除,这表明caspase-1炎性小体在体内caspase-7激活中起上游作用。相比之下,caspase-3的激活不需要caspase-1和炎性小体。总之,我们鉴定出了20种在caspase-1下游被激活的新底物,并在体外和基因敲除巨噬细胞中验证了caspase-1介导的caspase-7激活。这些结果首次证明了核苷酸结合和寡聚化结构域样受体/caspase-1/caspase-7级联的存在,以及caspase-3和-7在响应微生物刺激和细菌感染时存在不同的激活机制。